Chronic Pain and Opioid Use Disorder Increase Suicide Risk
Researchers evaluated the suicide risk for patients with chronic non-cancer pain and a co-occurring opioid use disorder.
Researchers evaluated the suicide risk for patients with chronic non-cancer pain and a co-occurring opioid use disorder.
A retrospective study of several US national databases evaluated the association between regional reductions in opioid prescribing with a reduction in total suicide deaths and opioid-specific suicide overdose deaths.
Researchers sought to evaluate the comparative effectiveness and safety of analgesics for acute low back pain.
Investigators sought to evaluate the association of comorbid PD and SUD with the probability of hospitalization among patients with COVID-19 in the emergency department.
Researchers sought to investigate symptom control with low-dose opioids in patients with refractory RLS.
Jim Anderson, MPAS, PA-C, wonders if SAMHSA will make the methadone take-home flexibility program permanent.
Brightly colored versions of the synthetic opioid fentanyl are appearing across the US, according to the Drug Enforcement Administration (DEA). In a press statement, the Agency reported that the colorful fentanyl, dubbed “rainbow fentanyl”, has been seized in 18 different states and has been found in multiple forms, including pills, powder, and blocks that resemble…
Pain and addiction specialists discuss the rise in workplace violence related to opioid denials and how to improve communication and change patient expectations.
During the workshop, speakers and panelists reviewed past programs that were put into place to reduce opioid prescribing, as well as trends in opioid prescribing and overdose deaths.
LYN-014 is an investigational oral, once-weekly, ultra-long-acting, extended-release levomethadone capsule to treat opioid use disorder.